Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Millipore Opens new Bioprocess Manufacturing Facility in Massachusetts

Published: Wednesday, June 10, 2009
Last Updated: Wednesday, June 10, 2009
Bookmark and Share
New facility will produce company’s Mobius® single-use product line used for biopharmaceutical manufacturing technologies.

Millipore Corporation has officially opened a new manufacturing facility in Danvers, Massachusetts. The over 30,000 square foot facility will produce a wide range of the company’s Mobius® single-use product line used for biopharmaceutical manufacturing technologies, including components of the newly introduced Mobius FlexReady Solutions.

Millipore Chairman, President and CEO Martin Madaus was joined by a number of state, regional and local dignitaries at today’s ribbon-cutting ceremony, including Massachusetts Lieutenant Governor Timothy Murray.

“The opening of our Danvers manufacturing facility is positive not only for Millipore, but for the state of Massachusetts as well,” said Madaus. “We made a decision to move manufacturing of this product line from California and bring it to Massachusetts, which will mean additional jobs in the state, not to mention an exciting, innovative technology that is already having an impact on biopharmaceutical manufacturing.”

Millipore expects the new facility will employ 120 before the end of 2009. The company currently employs over 1,000 in Massachusetts and almost 6,000 around the world.

Millipore’s Mobius FlexReady Solutions are made up of single-use assemblies (Flexware™), separation devices, and process-ready hardware systems optimized for clarification, media and buffer preparation, tangential flow filtration (TFF) and virus filtration unit operations. The systems provide operational flexibility and efficiency plus improved product safety and process time.

“The completion of our new Mobius manufacturing facility demonstrates our commitment to developing single-use technologies for our customers and our desire to continue our leadership role in bringing these solutions to the industry,” said Jean-Paul Mangeolle, President, Bioprocess Division, Millipore Corporation.

Today’s event also marks the official launch of Millipore’s Go Mobius Road Show, which features a mobile tradeshow that will travel across the country, presenting Millipore’s single-use innovation and core device expertise.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cellular Reprogramming – What the Future Holds
Advancements in cellular reprogramming are coming at a furious pace. Along with these scientific breakthroughs come new opportunities for the development of therapeutics, disease modeling, drug screening, and new pathways to personalized medicine.
Friday, July 23, 2010
Millipore Expands Drug Discovery and Development Services with BioAnaLab Acquisition
Acquisition extends Millipore’s biopharmaceutical services offering to European market.
Tuesday, August 11, 2009
Millipore and UMass Lowell Dedicate the Millipore Process Development Laboratory
Millipore announced the opening of the Millipore Corporation Process Development Laboratory in partnership with the university.
Friday, April 10, 2009
Millipore Announces Technology Acquisition to Strengthen Drug Discovery Product Offering
The purchase of Epitome Biosystems’ EpiTag™ technology assets will accelerate development of multiplex immunoassays for cell signaling.
Monday, March 02, 2009
Millipore Extends Exclusive License Agreement with University of Dundee
The ongoing collaboration will bring novel cell signaling tools and services to life science researchers worldwide.
Friday, October 10, 2008
ReNcell® VM Neural Stem Cell Line Models Parkinson’s Disease
Milipore announces the publication of a new discovery derived from its ReNcell VM neural stem cell line.
Tuesday, July 22, 2008
Millipore Unveils Expanded Drug Discovery Development Facility
The $3.4 million expansion will enable Millipore to keep pace with the growth of its worldwide drug discovery and development business.
Monday, June 30, 2008
Millipore Launches Progenitor Cell-Enriched Primary Human Epithelial Cell Cultures
According to Company, these primary cell cultures are designed to provide an enriched population of progenitor cells from skin, cornea, and bladder epithelia.
Friday, April 18, 2008
Millipore Launches Antibody Learning Center
The web tool is designed for navigating company’s antibody portfolio and planning efficient workflows for immunodetection in protein research.
Wednesday, April 16, 2008
Millipore Corporation and Novozymes Form Strategic Alliance to Supply Animal-Free Cell Culture Supplements for Bioprocessing
Alliance will accelerate launch of new animal-free supplements and provide customers with a source of high performance cell culture products.
Tuesday, December 18, 2007
Frost & Sullivan Commends Millipore’s Success in Developing Mammalian Gene Expression UCOE Technology
Millipore announced to be the recipient of the 2007 Frost & Sullivan Technology Innovation of the Year Award in the U.S. Drug Discovery Technologies market.
Monday, December 10, 2007
Millipore Announces Stem Cell Tested Initiative
Millipore’s Stericup with Express PLUS membrane is the first available under this initiative.
Wednesday, December 05, 2007
Millipore Launches new Website
Improved functions include product information, ordering and support.
Wednesday, October 31, 2007
Millipore Corporation Announces new ReNcell® Data from Collaboration with ReNeuron
Millipore releases new data concerning its ReNcell neural stem cell lines at the ISSCR meeting in Cairns, Australia on June 20, 2007.
Thursday, June 21, 2007
Millipore Announces Kinase Screening Agreement with Johnson & Johnson Pharmaceutical Research & Development
J&JPRD to supply potential protein kinase inhibitors for kinase selectivity profiling against Millipore's panel of 252 protein and lipid kinases.
Wednesday, January 17, 2007
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Genes Help Track Odd Migrations of Zika Mosquitoes
Study shows that mosquitoes carrying Zika virus or Dengue fever a genetically distinct around the world.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Driving Mosquito Evolution to Fight Malaria
Researchers propose insect repellent in conjunction with insecticides to extend current insecticide lifetime.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos